{"id":30561,"date":"2025-03-26T15:26:58","date_gmt":"2025-03-26T07:26:58","guid":{"rendered":"https:\/\/flcube.com\/?p=30561"},"modified":"2025-03-26T15:27:00","modified_gmt":"2025-03-26T07:27:00","slug":"burning-rock-reports-q4-revenue-growth-amid-improved-profitability","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=30561","title":{"rendered":"Burning Rock Reports Q4 Revenue Growth Amid Improved Profitability"},"content":{"rendered":"\n

Guangzhou-based medical device company Burning Rock (NASDAQ: BNR) has released its Q4 2024 financial results. The company reported Q4 revenues of RMB 126 million (USD 17.3 million), representing a 4.1% year-on-year (YOY) increase. For the full year, revenues reached RMB 515.8 million (USD 71 million), a 4.0% YOY decrease. Despite the annual revenue decline, the company’s operational efficiency and profitability continued to improve, achieving four consecutive quarters of profitability in 2024, excluding R&D and non-cash items.<\/p>\n\n\n\n

Business Segment Performance<\/strong>
In Q4, the in-hospital business segment saw significant growth, generating RMB 43.5 million (USD 6.0 million) in sales, a 50.9% YOY increase. This outpaced the central laboratory business, which reported sales of RMB 39.3 million (USD 5.4 million). Revenue from pharmaceutical research and development services reached RMB 43.3 million (USD 5.9 million) in Q4, a 5.6% YOY increase. For the full year, these services contributed RMB 115.7 million (USD 15.8 million) in sales, remaining relatively stable compared to 2023.<\/p>\n\n\n\n

Cost and Expense Management<\/strong>
The company’s R&D expenses for 2024 totaled RMB 232.3 million (USD 31.8 million), a 33.1% YOY decrease. Sales and marketing expenses amounted to RMB 190.9 million (USD 26.2 million), down 22.9% YOY. General and administrative expenses were RMB 261.6 million (USD 35.8 million), a 40.2% YOY reduction. The cost of revenues decreased by 11.9% YOY to RMB 153.4 million (USD 21.0 million) for 2024.<\/p>\n\n\n\n

Profitability and Financial Health<\/strong>
Gross profit remained stable at RMB 362.4 million (USD 49.6 million) for 2024, with the gross margin increasing to 70.3% from 67.6% in 2023. As of December 31, 2024, the company’s cash, cash equivalents, and restricted cash stood at RMB 522.2 million (USD 71.5 million).-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Guangzhou-based medical device company Burning Rock (NASDAQ: BNR) has released its Q4 2024 financial results….<\/p>\n","protected":false},"author":1,"featured_media":30562,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7],"tags":[724,27,1108],"class_list":["post-30561","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","tag-burning-rock","tag-finanical-reports","tag-nasdaq-bnr"],"yoast_head":"\nBurning Rock Reports Q4 Revenue Growth Amid Improved Profitability - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Guangzhou-based medical device company Burning Rock (NASDAQ: BNR) has released its Q4 2024 financial results. The company reported Q4 revenues of RMB 126 million (USD 17.3 million), representing a 4.1% year-on-year (YOY) increase. For the full year, revenues reached RMB 515.8 million (USD 71 million), a 4.0% YOY decrease. Despite the annual revenue decline, the company's operational efficiency and profitability continued to improve, achieving four consecutive quarters of profitability in 2024, excluding R&D and non-cash items.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=30561\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Burning Rock Reports Q4 Revenue Growth Amid Improved Profitability\" \/>\n<meta property=\"og:description\" content=\"Guangzhou-based medical device company Burning Rock (NASDAQ: BNR) has released its Q4 2024 financial results. The company reported Q4 revenues of RMB 126 million (USD 17.3 million), representing a 4.1% year-on-year (YOY) increase. For the full year, revenues reached RMB 515.8 million (USD 71 million), a 4.0% YOY decrease. Despite the annual revenue decline, the company's operational efficiency and profitability continued to improve, achieving four consecutive quarters of profitability in 2024, excluding R&D and non-cash items.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=30561\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-26T07:26:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-26T07:27:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2612-png.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"607\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30561#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30561\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Burning Rock Reports Q4 Revenue Growth Amid Improved Profitability\",\"datePublished\":\"2025-03-26T07:26:58+00:00\",\"dateModified\":\"2025-03-26T07:27:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30561\"},\"wordCount\":252,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30561#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/2612-png.webp\",\"keywords\":[\"Burning Rock\",\"Finanical Reports\",\"NASDAQ: BNR\"],\"articleSection\":[\"Company\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=30561#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30561\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=30561\",\"name\":\"Burning Rock Reports Q4 Revenue Growth Amid Improved Profitability - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30561#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30561#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/2612-png.webp\",\"datePublished\":\"2025-03-26T07:26:58+00:00\",\"dateModified\":\"2025-03-26T07:27:00+00:00\",\"description\":\"Guangzhou-based medical device company Burning Rock (NASDAQ: BNR) has released its Q4 2024 financial results. The company reported Q4 revenues of RMB 126 million (USD 17.3 million), representing a 4.1% year-on-year (YOY) increase. For the full year, revenues reached RMB 515.8 million (USD 71 million), a 4.0% YOY decrease. Despite the annual revenue decline, the company's operational efficiency and profitability continued to improve, achieving four consecutive quarters of profitability in 2024, excluding R&D and non-cash items.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30561#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=30561\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30561#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/2612-png.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/2612-png.webp\",\"width\":1080,\"height\":607,\"caption\":\"Burning Rock Reports Q4 Revenue Growth Amid Improved Profitability\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30561#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Burning Rock Reports Q4 Revenue Growth Amid Improved Profitability\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Burning Rock Reports Q4 Revenue Growth Amid Improved Profitability - Insight, China's Pharmaceutical Industry","description":"Guangzhou-based medical device company Burning Rock (NASDAQ: BNR) has released its Q4 2024 financial results. The company reported Q4 revenues of RMB 126 million (USD 17.3 million), representing a 4.1% year-on-year (YOY) increase. For the full year, revenues reached RMB 515.8 million (USD 71 million), a 4.0% YOY decrease. Despite the annual revenue decline, the company's operational efficiency and profitability continued to improve, achieving four consecutive quarters of profitability in 2024, excluding R&D and non-cash items.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=30561","og_locale":"en_US","og_type":"article","og_title":"Burning Rock Reports Q4 Revenue Growth Amid Improved Profitability","og_description":"Guangzhou-based medical device company Burning Rock (NASDAQ: BNR) has released its Q4 2024 financial results. The company reported Q4 revenues of RMB 126 million (USD 17.3 million), representing a 4.1% year-on-year (YOY) increase. For the full year, revenues reached RMB 515.8 million (USD 71 million), a 4.0% YOY decrease. Despite the annual revenue decline, the company's operational efficiency and profitability continued to improve, achieving four consecutive quarters of profitability in 2024, excluding R&D and non-cash items.","og_url":"https:\/\/flcube.com\/?p=30561","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-03-26T07:26:58+00:00","article_modified_time":"2025-03-26T07:27:00+00:00","og_image":[{"width":1080,"height":607,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2612-png.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=30561#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=30561"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Burning Rock Reports Q4 Revenue Growth Amid Improved Profitability","datePublished":"2025-03-26T07:26:58+00:00","dateModified":"2025-03-26T07:27:00+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=30561"},"wordCount":252,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=30561#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2612-png.webp","keywords":["Burning Rock","Finanical Reports","NASDAQ: BNR"],"articleSection":["Company"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=30561#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=30561","url":"https:\/\/flcube.com\/?p=30561","name":"Burning Rock Reports Q4 Revenue Growth Amid Improved Profitability - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=30561#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=30561#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2612-png.webp","datePublished":"2025-03-26T07:26:58+00:00","dateModified":"2025-03-26T07:27:00+00:00","description":"Guangzhou-based medical device company Burning Rock (NASDAQ: BNR) has released its Q4 2024 financial results. The company reported Q4 revenues of RMB 126 million (USD 17.3 million), representing a 4.1% year-on-year (YOY) increase. For the full year, revenues reached RMB 515.8 million (USD 71 million), a 4.0% YOY decrease. Despite the annual revenue decline, the company's operational efficiency and profitability continued to improve, achieving four consecutive quarters of profitability in 2024, excluding R&D and non-cash items.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=30561#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=30561"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=30561#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2612-png.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2612-png.webp","width":1080,"height":607,"caption":"Burning Rock Reports Q4 Revenue Growth Amid Improved Profitability"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=30561#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Burning Rock Reports Q4 Revenue Growth Amid Improved Profitability"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2612-png.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/30561","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=30561"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/30561\/revisions"}],"predecessor-version":[{"id":30563,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/30561\/revisions\/30563"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/30562"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=30561"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=30561"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=30561"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}